Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
29,017.22
(
1.10%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
95.41
(
-5.70%
)
Bitcoin
77,416.22
(
0.19%
)
News Focus
News Focus
Post# of 257628
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: srsmgja post# 81075

Tuesday, 07/28/2009 1:46:05 AM

Tuesday, July 28, 2009 1:46:05 AM

Post# of 257628
Copaxone vs Tysabri in the US Market 
 
       Tysabri    Copaxone  
      sales ($M) sales ($M)  
 2Q09    125        438  
 1Q09    116        430  
 4Q08    115        384  
 3Q08    122        352
The cumulative growth of US Tysabri sales during the past three quarters has been 2.5%.

The cumulative growth of US Copaxone sales during the past three quarters has been 24.4%.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today